ClinicalTrials.gg
RecruitingNCT07491549Updated Mar 30, 2026

The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity

An interventional study of pain education in Chronic Pain, sponsored by University of Tartu. Recruiting at 1 site in Estonia. Open to participants aged 16 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-03-30.

Sponsored by University of Tartu · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
16 Years to 65 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn if pain knowledge group intervention among chronic pain patients would influence their level of physical activity, pain intensity, depression, kinesiophobia and central sensitization. The main question it aims to answer is:

Primary hypothesis: pain education will decrease participants' depression and pain intensity and increase their physical activity.

There is no comparison group.

Participants will participate in a 6-week pain knowledge intervention where they will be learning about sleep, stress models, physical activity benefits, pain neurobiology, mindfulness, pain medication.

02

Conditions studied

  • Chronic Pain

Keywords

  • chronic pain
  • depression
  • pain education
  • physical activity
  • kinesiophobia
03

In context

Chronic Pain

3,227 studies on the registry are indexed under Chronic Pain; 729 are open to participants now.

This study's planned enrollment of 50 is below the median of 60 across 2,388 interventional studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

University of Tartu is the lead sponsor of 46 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pain lasting longer than 3 months,
  • Consequences resulting from long-term pain (such as decreased physical activity, sleep disturbances, fatigue, low mood, etc.)

Exclusion criteria

Exclusion Criteria:

  • Surgery that occurred less than 3 months prior
  • Fracture or limb trauma that occurred less than 3 months prior
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Pain education intervention

    The participants will receive a 6-week pain education in groups. In addition, they are asked to wear an Actigraph to measure their actual physical activity. The topics in the pain education group are as follows: 1. The pain management team - the patient as the supportive leader of the team 2. Contemporary understanding of the biopsychosocial nature of pain 3. Stress and its impact on pain 4. Use of medications in the treatment of chronic pain 5. Physical activity and its impact on pain 6. Negative thoughts and their impact on pain 7. Use of relaxation and mindfulness techniques in pain management 8. Sleep and sleep hygiene 9. Setbacks and coping with them

    Behavioral: pain education

Interventions

  • Behavioralpain education

    In one group there will be 8-12 participants who will meet once a week during 6 -weeks time. The educational sessions will be 2-hours long including sometimes some exercises and also reflection of the participants.

    Also known as: pain neuroscience education, pain management education

06

What researchers measure

Primary outcomes

  1. Change of pain intensity from baseline to 6-weeks

    Pain is measured using Graded Chronic Pain Scale -Revised where the lowest value is 0 and the highest is 100. The higher the score, the more pain the subject feels.

    Time frame: from enrollment to the end of treatment at 6 weeks

  2. Change of pain intensity from baseline to 6-weeks

    Pain is measured using Brief Pain Inventory Short form where the lowest value is 0 and the highest value is 10. The higher the score, the more pain the subject feels.

    Time frame: from enrollment to the end of treatment at 6 weeks

Secondary outcomes

  1. Change in depression from baseline to 6-weeks

    Depression is measured using Emotional well-being questionnaire where the lowest value is 0 and the highest value is 100. Lower score indicates worse health condition.

    Time frame: from enrollment to the end of treatment at 6 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — We might share the data of the participants on OpenScience Platform

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07491549
Lead sponsor
University of Tartu
Responsible party
Hanna Kalajas-Tilga (Lecturer of physiotherapy in the Sports Sciences and Physiotherapy institute, University of Tartu) — Principal investigator
First posted
Mar 24, 2026
Start date
Apr 1, 2026 (estimated)
Primary completion
May 31, 2030 (estimated)
Completion
Dec 30, 2030 (estimated)
Last update
Mar 30, 2026

Study contacts

Hanna Kalajas-Tilga, PhD
Contact
hanna.kalajas-tilga@ut.ee
+372 5816 1041
Mati Arendi, PhD
Contact

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion